UAE to adopt convalescent plasma therapy for COVID-19 treatment

The UAE has decided to adopt and implement the convalescent plasma therapy as a new treatment for the COVID-19 during the course of the coming week.

Under the UAE’s guideline, the Dubai Health Authority (DHA) is to start using the blood plasma from recovered COVID-19 patients based on international standards, presuming that the cured patients have developed antibodies to fight the virus that stays in the blood to fight the same virus.

“The DHA has introduced the protocol for convalescent plasma therapy at DHA hospitals and private hospitals in Dubai, in an important step towards the treatment and prevention of the spread of COVID-19,” said Dr. Younis Kazim, CEO of Dubai Healthcare Corporation at the DHA.

Dr. Younis Kazim added that, the US Food and Drug Administration revealed that it was scientifically proven that the use of convalescent plasma therapy helped speed the recovery of COVID-19 patients, decreasing the number of days they spend in hospital.

Guidelines and rules have been laid by the DHA specifying who can make based plasma donations and who is eligible to receive this treatment.

Comments are closed, but trackbacks and pingbacks are open.